These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12519840)

  • 1. Prediction of response to growth hormone treatment in short children born small for gestational age: analysis of data from KIGS (Pharmacia International Growth Database).
    Ranke MB; Lindberg A; Cowell CT; Wikland KA; Reiter EO; Wilton P; Price DA;
    J Clin Endocrinol Metab; 2003 Jan; 88(1):125-31. PubMed ID: 12519840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of a mathematical model for predicting the response to exogenous recombinant human growth hormone (GH) in prepubertal children with idiopathic GH deficiency. KIGS International Board. Kabi Pharmacia International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1174-83. PubMed ID: 10199749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: analysis of data from KIGS.
    Ranke MB; Lindberg A; Albertsson-Wikland K; Wilton P; Price DA; Reiter EO
    J Clin Endocrinol Metab; 2005 Apr; 90(4):1966-71. PubMed ID: 15634724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early, discontinuous, high dose growth hormone treatment to normalize height and weight of short children born small for gestational age: results over 6 years.
    de Zegher F; Du Caju MV; Heinrichs C; Maes M; De Schepper J; Craen M; Vanweser K; Malvaux P; Rosenfeld RG
    J Clin Endocrinol Metab; 1999 May; 84(5):1558-61. PubMed ID: 10323379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
    Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year growth response to growth hormone treatment in very young children born small for gestational age-data from KIGS.
    Boguszewski MC; Lindberg A; Wollmann HA
    J Clin Endocrinol Metab; 2014 Aug; 99(8):2683-8. PubMed ID: 24758180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y; Mulder P; Houdijk M; Jansen M; Reeser M; Hokken-Koelega A
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3584-90. PubMed ID: 12915640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone treatment in short children born prematurely--data from KIGS.
    Boguszewski MC; Karlsson H; Wollmann HA; Wilton P; Dahlgren J
    J Clin Endocrinol Metab; 2011 Jun; 96(6):1687-94. PubMed ID: 21430029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB; Lindberg A; Price DA; Darendeliler F; Albertsson-Wikland K; Wilton P; Reiter EO;
    Horm Res; 2007; 68(2):53-62. PubMed ID: 17228181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adult height in short children born SGA treated with growth hormone and gonadotropin releasing hormone analog: results of a randomized, dose-response GH trial.
    Lem AJ; van der Kaay DC; de Ridder MA; Bakker-van Waarde WM; van der Hulst FJ; Mulder JC; Noordam C; Odink RJ; Oostdijk W; Schroor EJ; Sulkers EJ; Westerlaken C; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2012 Nov; 97(11):4096-105. PubMed ID: 22904179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting the response to growth hormone treatment in short children with chronic kidney disease.
    Mehls O; Lindberg A; Nissel R; Haffner D; Hokken-Koelega A; Ranke MB
    J Clin Endocrinol Metab; 2010 Feb; 95(2):686-92. PubMed ID: 20008024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database).
    Ranke MB; Lindberg A;
    BMC Med Inform Decis Mak; 2011 Jun; 11():38. PubMed ID: 21627853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
    Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone (GH)-binding protein in prepubertal short children born small for gestational age: effects of growth hormone treatment. Swedish Study Group for Growth Hormone Treatment.
    Boguszewski M; Bjarnason R; Rosberg S; Carlsson LM; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1014-9. PubMed ID: 9100566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
    Sas T; Mulder P; Hokken-Koelega A
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of long-term response to recombinant human growth hormone in Turner syndrome: development and validation of mathematical models. KIGS International Board. Kabi International Growth Study.
    Ranke MB; Lindberg A; Chatelain P; Wilton P; Cutfield W; Albertsson-Wikland K; Price DA;
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4212-8. PubMed ID: 11095456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Head circumference and body proportions before and during growth hormone treatment in short children who were born small for gestational age.
    Arends NJ; Boonstra VH; Hokken-Koelega AC
    Pediatrics; 2004 Sep; 114(3):683-90. PubMed ID: 15342839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth response in prepubertal children with idiopathic growth hormone deficiency during the first two years of treatment with human growth hormone. Analysis of the Kabi Pharmacia International Growth Study.
    Ranke MB; Guilbaud O
    Acta Paediatr Scand Suppl; 1991; 379():109-15; discussion 116. PubMed ID: 1815451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction model for adult height of small for gestational age children at the start of growth hormone treatment.
    de Ridder MA; Stijnen T; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2008 Feb; 93(2):477-83. PubMed ID: 18000093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
    Cutfield WS; Lundgren F
    Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.